Non-infected hemodialysis catheters are associated with increased inflammation compared with arteriovenous fistulas.

Y. Solak,H. Atalay

DOI: https://doi.org/10.1038/ki.2010.55

IF: 19.6

2010-05-02

Kidney International

Abstract:

What problem does this paper attempt to address?

Dr. David Coston Sabiston: A Stalwart of Surgical Training and Innovations

Himanshu Agrawal,Nikhil Gupta,Himanshu Tanwar

DOI: https://doi.org/10.1007/s12262-024-04104-y

2024-06-25

Indian Journal of Surgery

Abstract:Dr. David Coston Sabiston is a pioneer surgeon and an innovator in cardio-thoracic surgery. An image of excellence among surgical trainees across the globe. As chairman of the department of surgery at Duke University, he was reputedly one of the greatest surgeons who ever lived. In 1962, he grafted a vein from a patient's leg to feed blood past a blocked coronary artery, very first coronary artery bypass grafting (CABG), and promptly known as a moderniser of cardiac surgery. He was the president of all the principal surgical societies in America.

surgery
From Catheters To Ventricular Assist Devices: 60 Years of Cardiovascular Experiences With William L. Winters, JR., M.D.

W. L. Winters

DOI: https://doi.org/10.14797/mdcj-11-3s1-1

2015-09-10

Methodist DeBakey Cardiovascular Journal

Abstract:Automatic typewriters, transistor radios, microfiche, black and white television…while considered high-tech in the 1950s, these technologies seem limited when viewed from the 21st century. The same is true for cardiovascular medicine, which back then relied on electrocardiograms and X-rays for most diagnoses. In the 60 years since, advances in medical capabilities have progressed at a staggering pace. Patient research that once required months poring over paper charts is now reduced to hours using electronic medical record databases. Diagnostic images that once took days to process can now be accessed instantly through ultrasound and magnetic resonance imaging. While a half-century ago no one would have imagined accessing any and all information with a 5-second Google search, so too would noninvasive heart surgery been considered unimaginable. Since the 1950s when he graduated from medical school, William L. Winters, Jr., has been a first-hand witness to breathtaking innovations in cardiovascular medicine-both globally and in Houston. Author of Houston Hearts: A History of Cardiovascular Surgery and Medicine at Houston Methodist DeBakey Heart & Vascular Center and long-time medical editor of the Methodist DeBakey Cardiovascular Journal, Dr. Winters sat down with the journal editors this past April to share his insights from the last half-century of medical practice.
Vivien Theodore Thomas (1910–1985): An African-American laboratory technician who went on to become an innovator in cardiac surgery

Erdinc Soylu,Thanos Athanasiou,Omar A Jarral

DOI: https://doi.org/10.1177/0967772015601566

2015-08-25

Journal of Medical Biography

Abstract:Vivien Theodore Thomas (1910–1985) was an African-American laboratory technician and instructor of surgery at Johns Hopkins University, Baltimore. He was born as the grandson of a slave in Lousiana, working as a carpenter and subsequently as a laboratory technician after the great depression and the loss of his savings derailed his plans to become a doctor. In his role as a laboratory technician, he overcame challenging personal circumstances to become an innovator in paediatric cardiac surgery, despite having no formal college education. He played an important role in assisting Alfred Blalock and Helen Taussig in the development of the ‘Blalock-Taussig’ shunt, a procedure used to improve the survival of children with cyanotic congenital heart defects. He also contributed to major breakthroughs in research covering a spectrum of disorders such as traumatic shock, coarctation of the aorta and transposition of the great arteries. He acted as a teacher and mentor to a generation of surgical residents and technicians who went on to become leaders in their field across the USA. A television film based on his life was premiered by HBO in 2004 titled ‘Something the Lord made’.
Making heart-lung machines work in India: Imports, indigenous innovation and the challenge of replicating cardiac surgery in Bombay, 1952-1962

David S Jones,Kavita Sivaramakrishnan

DOI: https://doi.org/10.1177/0306312718794034

Abstract:In 1962, surgeons at two hospitals in Bombay used heart-lung machines to perform open-heart surgery. The devices that made this work possible had been developed in Minneapolis in 1955 and commercialized by 1957. However, restrictions on currency exchange and foreign imports made it difficult for surgeons in India to acquire this new technology. The two surgeons, Kersi Dastur and PK Sen, pursued different strategies to acquire the ideas, equipment, and tacit knowledge needed to make open-heart surgery work. While Dastur tapped Parsi networks that linked him to local manufacturing expertise, Sen took advantage of opportunities offered by the Rockefeller Foundation to access international training and medical device companies. Each experienced steep learning curves as they pursued the know-how needed to use the machines successfully in dogs and then patients. The establishment of open-heart surgery in India required the investment of substantial labor and resources. Specific local, national, and transnational interests motivated the efforts. Heart-lung machines, for instance, took on new meanings amid the nationalist politics of independent India: Even as surgeons sought imported machines, they and their allies assigned considerable value to 'indigenous' innovation. The confluence of the many interests that made Sen and Dastur's work possible facilitated the uneasy co-existence of conflicting judgments about the success or failure of this medical innovation.
The unreliability of tactile tension.

J. E. McDonald,W. M. Caygill

DOI: https://doi.org/10.1001/JAMA.1957.72980270001010

1957-11-02

Journal of the American Medical Association

Abstract:There is a widespread belief among the medical profession including some ophthalmologists that the determination of ocular tension by palpation through the lids offers a fairly reliable estimation of the level of intraocular pressure for the diagnosis of glaucoma. Numerous patients with failing vision are seen with irreparable glaucomatous damage to the optic nerve because of undiagnosed glaucoma. Most of these patients have open-angle or chronic simple glaucoma because the insidious nature of the disease had given them no warning. A significant number have lost visual field progressively because someone missed the diagnosis by relying on the tactile method of estimating ocular tension. The normal intraocular pressure ranges up to about 27 mm. Hg as measured with the Schiotz tonometer. In untreated cases of chronic simple glaucoma (openangle) the tension usually runs higher than this. Although pressures in this condition may range up to 60 mm. Hg as measured with
Kenneth Keown (1917-1985): Innovator in Early Cardiac Anesthesiology

Janette D McVey,Julie M Marshall,Quinn L Johnson,Frederick O'Donnell

DOI: https://doi.org/10.7759/cureus.67309

2024-08-20

Cureus

Abstract:Kenneth Keown, MD, was a forward-thinking anesthesiologist who developed techniques to allow the safe practice of cardiac anesthesia and opened the door for the future development of more complex intracardiac surgical procedures. His early successful protocols for cardiac anesthesiology and his wide-reaching education of others on these methods earned him the designation of "the grand old man of anesthesia for inside-the-heart surgery" at a young age. His contributions also extended to groundbreaking research in hypothermia, lidocaine uses as an antiarrhythmic, and advocacy for anesthesiology as a specialty. We highlight the accomplishments of Dr. Keown that may be unrecognized by those outside the field of cardiac anesthesiology, as they paved the way for the success of modern cardiac surgery.
Surgical Treatment on Congenital Heart Disease with Severe Pulmonary Hypertension

Y. L. Liu,J. B. Huang,B. Kong,S. S. Hu,X. D. Shen,S. J. Li,X. Wang,J. Yan,X. Wu

DOI: https://doi.org/10.3969/j.issn.1008-0074.2003.05.017

2003-01-01

Abstract:Objective: To study the experience and efficacy of 32 patients with congenital heart disease combined with severe pulmonary hypertension. Methods:The clinical data of 32 patients were studied retrospectively. All the patients showed cyanosis after physical activity and accepted echocardiogram measure showed bi-directed shunt at the defects. The intracardiac malformation included ventricular septal defects (VSD) 22 cases, VSD with atrial septal defects (ASD) 5 cases, VSD with patent ductus arteriosus (PDA) 5 cases. Among 32 cases, 6 cases were accepted the operation on cardioplegic heart arrested, while 26 on beating heart. Using auto-pericardium repaired ASD and made a valve that allowed only right-to-left shunt. If no ASD, the valve was done at the oval fosse. Results: There were 3 cases of early surgical deaths (9.4%, 3/32). Every patient accompanied with hypoxia, and need more long mechanical support but no case needs tracheolaryngotomy. There were 2 (6. 3%, 2/32) cases of late deaths and 3 (9.4%, 3/32) cases of late heart function failure followed-up from two months to eighty-six months. The other patients (75%, 24/32) recovered well. Conclusion: On-pump with beating heart is an effective myocardial protective technique in patients with congenital heasrt disease combined with severe pulmonary hypertension. It contribute to early recovery for the patients with severe pulmonary hypertension by doing the valves on atrial septum.
In vitro and in vivo suppression of gluconeogenesis by inhibition of pyruvate carboxylase.

Joseph J. Bahl,M. Matsuda,Ralph A. DeFronzo,Rubin Bressler

DOI: https://doi.org/10.1016/S0006-2952(96)00660-0

IF: 6.1

1997-01-10

Biochemical Pharmacology

Abstract:
Heart valve disease: a journey of discovery

Laura Elizabeth Dobson,Bernard D Prendergast,Dobson,L. E.,Prendergast,B. D.

DOI: https://doi.org/10.1136/heartjnl-2021-320146

IF: 5.7

2022-04-22

Heart

Abstract:In the centenary year of the British Cardiovascular Society (BCS), this review article outlines the influence of UK cardiologists and surgeons on the field of heart valve disease, many of whom can rightly claim 'world firsts' in the field. From the description of endocarditis as we know it today at the turn of the 20th century, to the first mitral valvotomy, heart valve replacement and invention of the Ross procedure. These advances have transformed the outlook of patients with symptomatic valve disease from palliation and certain death to curative treatment and near normal life expectancy. Transcatheter aortic valve implantation (TAVI) was adopted early in the UK, and thanks to the comprehensive national database, the UK TAVI registry is one of the world's largest, contributing real-world patient data to inform clinical practice. The more recent concepts of 'Heart Valve Centres of Excellence' and specialist valve clinics have been developed by the BCS-affiliated British Heart Valve Society which continues to drive improved standards for patients with heart valve disease. The next 100 years will no doubt be equally thrilling in terms of innovation for heart valve disease, with artificial intelligence, transcatheter therapies and cutting-edge technology continuing to improve patient care and clinical outcomes.

cardiac & cardiovascular systems
Master John of Arderne (1307-1380): a founder of modern surgery

John Pearn

DOI: https://doi.org/10.1111/j.1445-2197.2011.05670.x

Abstract:Background: John of Arderne (1307-1380) was one founder of surgery as the profession is known today. He was the first English surgeon of whom biographic details survive. Born on the Arderne Estates at Newark, England, he served as a military surgeon in France in campaigns where gunpowder was used in combat for the first time. His best-known work, the Practica (De Arte Phisicali et de Cirurgia), formed the basis of practical surgical teaching in the medical schools of medieval Europe. Method: Biographic research of primary and secondary archives and documents. Results: John of Arderne's surgical practice was undertaken against a background of turbulent political, military and medical events. He survived the Black Death (1347) and its cyclical recurrences. He lived through the turbulent reigns of Edward II and Edward III and practised in London in the decades preceding the simmering unrest which preceded the Peasant's Revolt of 1381. Surgical and medical practice in the late Middle Ages was enmeshed in astrological beliefs. It was greatly influenced by church doctrine of disease causation. Conclusion: In this paper, the known details of John of Arderne's life are placed in the perspective of these societal and professional influences. He is one of several pre-Renaissance European doctors who were the first to challenge the received medical lore of Galen and later Arabic surgeons. Writing when he was 70 years of age, John of Arderne was the first to advocate that surgeons should trust their own clinical experience 'Wele ymagynyng subtile things' rather than following the directions of others, even including those advocated by himself.
Lessons for Cardiovascular Clinical Investigators: The Tumultuous 2,500-Year Journey of Physicians Who Ignited Our Fire

Milton Packer

DOI: https://doi.org/10.1016/j.jacc.2024.03.420

2024-07-02

Abstract:Whereas medical practice stems from Hippocrates, cardiovascular science originates with Aristotle. The Hippocratic philosophy was championed by Galen (129-216 CE), whose advocacy of a tripartite soul found favor in the early Christian Church. In contrast, Aristotle's works were banned as heresy by ecclesiastical authority, only to survive and prosper in the Islamic Golden Age (775-1258 CE). Galen theorized that the circulation consisted of separate venous and arterial systems. Blood was produced in the liver and traveled centrifugally through veins. When arriving in the right ventricle, venous blood passed through tiny pores in the ventricular septum into the left ventricle, where it became aerated by air passing from the lungs through the pulmonary veins to the left side of the heart. Following arrival at distal sites, arterial blood disappeared, being consumed by the tissues, requiring that the liver needed to continually synthesize new blood. The heart was viewed as a sucking organ, and the peripheral pulse was deemed to result from changes in arterial tone, rather than cardiac systole. Galen's framework remained undisputed and dominated medical thought for 1,300 years, but the reintroduction of Aristotelian principles from the Islamic world into Europe (through the efforts of the Toledo School of Translators) were nurtured by the academic freedom and iconoclastic environment uniquely cultivated at the University of Padua, made possible by Venetian rebellion against papal authority. At Padua, the work of Andreas Vesalius, Realdo Colombo, Hieronymus Fabricius ab Acquapendente, and William Harvey (1543-1628) methodically destroyed Galen's model, leading to the modern concept of a closed-ended circulation. Yet, due to political forces, Harvey was ridiculed, as was James Lind, who performed the first prospective controlled trial, involving citrus fruits for scurvy (1747); it took nearly 50 years for his work to be accepted. Even the work of William Withering (1785), the father of cardiovascular pharmacology, was tarnished by professional jealously and the marketing campaign of a pharmaceutical company. Today's cardiovascular investigators should understand that major advances are routinely derided by the medical establishment for political or personal reasons; and it may take decades or centuries for important work to be accepted.
Pericardiectomy and Mechanical Mitro-Aortic Valve Replacement in a Young Patient With Erdheim-Chester Disease

Nerea Lopez Perez,Mathieu van Steenberghe,Jörg D. Seebach,Philippe Meyer,Johannes Alexander Lobrinus,Christoph Huber,Mustafa Cikirikcioglu

DOI: https://doi.org/10.14503/thij-23-8201

2024-02-07

Texas Heart Institute Journal

Abstract:Abstract Erdheim-Chester disease is a rare histiocytosis that primarily affects the skeletal system, but cardiovascular manifestations occur in 75% of cases and are associated with a poor prognosis. Given the small number of cases, the evolution and management of the disease are uncertain. Therefore, it is important to report and share Erdheim-Chester cases. This report presents the case of a young patient with constrictive pericarditis and mitral valve regurgitation resulting from Erdheim-Chester disease.

cardiac & cardiovascular systems
Charles L Christian

Mary K Crow,Josef S Smolen,Mary K. Crow,Josef S. Smolen

DOI: https://doi.org/10.1016/j.rdc.2023.09.002

IF: 2.032

2024-02-01

Rheumatic Disease Clinics of North America

Abstract:Dr Charles L Christian arrived in New York City in 1953, having grown up in Wichita, Kansas, and graduating from medical school at Case Western Reserve in Cleveland, Ohio. In New York, Dr Christian embarked on training in internal medicine at Columbia's Presbyterian Hospital where he met an individual who would shape the course of his career, Dr Charles Ragan, a founder of the Arthritis Foundation. Dr Christian, or Chuck as he was usually called, went on to shape the developing field of rheumatology, advancing understanding of our most complex diseases as an investigator, master clinician, mentor, and academic leader. During an era when the cellular and humoral features of the immune system were just coming into focus, Chuck performed laboratory experiments with precision and creativity to achieve new understanding of 3 significant diseases: rheumatoid arthritis, systemic lupus erythematosus, and vasculitis. Review of his publications from the 1950s and 1960s provides a window into a time when figures were hand drawn and papers often had a single author. While the tools of technology that we rely on today were not available to Chuck, his insights have had a sustained impact on how we understand and treat autoimmune rheumatic diseases. His talents and his dedication to patients, colleagues, science, and medicine supported a lifetime of remarkable contributions.

rheumatology
Renaissance-Europe-17th Century

Jeremy C Ganz

DOI: https://doi.org/10.1016/bs.pbr.2024.02.015

Abstract:The authors of the texts described in this chapter will have had access to the anatomy of Vesalius; a marked step forward. However, there was no equivalent advance in physiology. Harvey's book on the circulation of the blood was published in 1628 but it took many years for its contents to be accepted as standard teaching. The century saw the development of instruments some of which look more like instruments a modern surgeon would recognize. The two major technical advances were the acceptance of a single-handed trephine and the design of crown trepans with a conical shape and blades extending up the sides. Moreover, the crown trepan had once again become the favored instrument for gaining access to the interior of the cranium. In terms of technique there was a worrying trend that surgeons could feel when they had penetrated the inner table of the skull without the need to probe. All the way back to Hippocrates, it had been customary to use probes to assess depth while trepanning. Thus, the abandonment of this safety measure if it was real, is cause for concern. However, it is not impossible that probing was continued and simply not mentioned as it was so obviously necessary as not to require comment. The lenticular illustrated remains of the triangular shape first illustrated by Vidius. It is important to note that it was not used to incise the skull but to smooth of rough edges and spicules.
Fracture of the tibial tray following PCA knee replacement

M. Maruyama,K. Terayama,H. Sunohara,T. Adachi,S. Suzuki,T. Fukuzawa

DOI: https://doi.org/10.1007/BF00426182

IF: 2.928

1994-10-01

Archives of Orthopaedic and Trauma Surgery

Abstract:
Truncated ambition: Thomas King Chambers, MD (1817–1889)

Susan Drain

DOI: https://doi.org/10.1177/0967772014526316

2014-03-27

Journal of Medical Biography

Abstract:Thomas King Chambers clearly intended to be a physician of note and at times indeed he was mentioned in the same breath as Sir James Paget (1814–1899), Sir Henry Acland (1815–1900) and Francis Anstie (1833–1874). At the time of his death his career was pronounced ‘less than brilliant though far from inglorious’. He had made all the right political moves—networking through the medical societies, marrying well and even accompanying the Prince of Wales on his first foreign tour. He wanted to be more than a society doctor, however: he published his clinical lectures and original research, proposed a new paradigm for medicine that he dubbed ‘the renewal of life’ and found his ideas taken up enthusiastically in the United States. Alas, his career foundered when he suffered an aneurysm and underwent amputation through the thigh. Nevertheless, he made significant contributions to the profession through his service on the General Medical Council and to medical education, in particular to medical education for women, through his strong support of the London School of Medicine for Women. To examine his life is to revisit what makes a life meaningful and worthwhile, for Chambers’ life, unlike his body, is remarkably whole.
50th Anniversary of the first successful permanent pacemaker implantation in the United States: historical review and future directions

Hiroko Beck,William E Boden,Sushmitha Patibandla,Dmitriy Kireyev,Vipul Gutpa,Franklin Campagna,Michael E Cain,Joseph E Marine

DOI: https://doi.org/10.1016/j.amjcard.2010.04.043

2010-09-15

Abstract:June 2010 marks the 50th anniversary of the first successful human cardiac pacemaker implantation in the United States. On June 6, 1960, in Buffalo, New York, Dr. William Chardack implanted a pacemaker, designed and built by Wilson Greatbatch, an electrical engineer and inventor, in a 77-year old man with complete atrioventricular block, extending the patient's life by 18 months. This landmark event ushered in a new era of implantable cardiac pacemakers with batteries and leads of high reliability and increasing durability. Over the past half century, the field of electrophysiology and implantable devices for the management of cardiac conduction disturbances has evolved dramatically. Today's pacemakers include increasingly complex features such as telemetry monitoring, auto programmability, and hemodynamic sensors. New-generation leads present a sophisticated design with improved geometry and steroid-eluting tips to reduce chronic inflammation, maintaining a low pacing threshold and high sensing capability. The lithium iodide battery remains the mainstay of implantable pacemaker systems, exhibiting a multiple-year lifespan, slow terminal decay, and a reduced size and cost of production. Although Greatbatch's first successful pacemaker implantation remains a seminal scientific contribution to modern cardiovascular disease management, emerging developments in this field may challenge its preeminence. Important challenges such as imaging compatibility, lead durability, and infection prevention are being addressed. Novel concepts such as leadless and biologic pacing are under active investigation. In conclusion, Greatbatch's historic achievement 50 years ago reminds us that technologic progress is timeless, as efforts to enhance clinical outcomes and the quality of life continue unimpeded into the 21st century.
Robert R. Shaw, MD: thoracic surgical hero, Afghanistan medical pioneer, champion for the patient, never a surgical society president

Harold C Urschel Jr,Betsey Bradley Urschel

DOI: https://doi.org/10.1016/j.athoracsur.2012.03.060

Abstract:Dr Robert R. Shaw arrived in Dallas to practice Thoracic Surgery in 1937, as John Alexander's 7th Thoracic Surgical Resident from Michigan University Medical Center. Dr Shaw's modus operandi was, "You can accomplish almost anything, if you don't care who gets the credit." He was a remarkable individual who cared the most about the patient and very little about getting credit for himself. From 1937 to 1970, Dr Shaw established one of the largest lung cancer surgical centers in the world in Dallas, Texas. It was larger than M.D. Anderson and Memorial Sloan-Kettering Hospitals put together regarding the surgical treatment of lung cancer patients. To accomplish this, he had the help of Dr Donald L. Paulson, who trained at the Mayo Clinic and served as Chief of Thoracic Surgery at Brook Army Hospital during the Second World War. Following the War, because of his love for Texas, he ended up as a partner of Dr Shaw in Dallas. Together, they pursued the development of this very large surgical lung cancer center. Dr Shaw and his wife Ruth went to Afghanistan with Medico multiple times to teach men modern cardiac and thoracic surgery. They also served as consultants on Medico's Ship of Hope in Africa. Dr Shaw initiated multiple new operations including: 1) resection of Pancoast's cancer of the lung after preoperative irradiation; 2) upper lobe of the lung bronchoplasty, reattaching (and saving) the lower lobe to prevent the "disabling" pneumonectomy; and 3) resections of pulmonary mucoid impaction of the lung in asthmatics. Because of his humility and giving "the credit to others," Dr Shaw was never President of a major medical or surgical association.
Oh, the places we’ll go

J Mocco

DOI: https://doi.org/10.1136/neurintsurg-2022-018862

IF: 4.8

2022-03-18

Journal of NeuroInterventional Surgery

Abstract:The first percutaneous coronary angioplasty was performed in September 1977 in Zurich, Switzerland.1 Less than 10 years later, intra-arterial stents were introduced as a viable treatment for coronary artery disease,2 and by 1994 coronary stenting was an established standard of care for percutaneous coronary intervention.3 4 This rapid growth and the resulting lives saved are impressive. However, interventional cardiology has grown into a field much broader and more complex than the opening of clogged arteries. It is now well accepted that an appropriately trained interventional cardiologist can replace leaky cardiac valves, close a patent foramen ovale, seal off atrial appendages, place electric leads to record the heart—or even defibrillate it, and completely alter a heart's electrophysiological pathways with targeted ablation. The modern interventional cardiologist is not only a plumber, but also an electrician, and a carpenter. Which begs the question ......

surgery,neuroimaging
Historical landmarks in the development of robotic coronary bypass grafting

Johannes Bonatti

DOI: https://doi.org/10.21037/acs-2023-rcabg-0186

2024-07-31

Abstract:Robotic technology was first used in history for the minimally invasive surgical treatment of coronary artery disease. In 1998, the first operations were carried out at the Hôpital Broussais in Paris. Thereafter, several European and United States (US) centers developed surgical concepts for robotically assisted internal mammary artery harvesting and the construction of the anastomoses, either through minithoracotomy or in a totally endoscopic fashion. Initial experiences were documented in a number of single and multicenter series published in the early and mid-2000s. Key steps in further procedure development included the introduction of a robotic endostabilizer for beating heart completely endoscopic operations, the combination with percutaneous coronary intervention in hybrid approaches, the introduction of second, third, and fourth generations of surgical robots with improvements in each iteration, the availability of anastomotic devices, and most recently, the emergence of new robotic technology companies producing interesting alternatives to the existing machines. The larger clinical series included 500 to over 1,000 patients, with clinical results that well justified the continued application of robotics. Development of robotic coronary bypass grafting has generally been slow, but at committed centers, the procedures are routine, reproducible, safe, and effective. Over 25 years of development, robotic surgical coronary revascularization has become an important component in the armamentarium of minimally invasive heart surgery.

Non-infected hemodialysis catheters are associated with increased inflammation compared with arteriovenous fistulas.

Dr. David Coston Sabiston: A Stalwart of Surgical Training and Innovations

From Catheters To Ventricular Assist Devices: 60 Years of Cardiovascular Experiences With William L. Winters, JR., M.D.

Vivien Theodore Thomas (1910–1985): An African-American laboratory technician who went on to become an innovator in cardiac surgery

Making heart-lung machines work in India: Imports, indigenous innovation and the challenge of replicating cardiac surgery in Bombay, 1952-1962

The unreliability of tactile tension.

Kenneth Keown (1917-1985): Innovator in Early Cardiac Anesthesiology

Surgical Treatment on Congenital Heart Disease with Severe Pulmonary Hypertension

In vitro and in vivo suppression of gluconeogenesis by inhibition of pyruvate carboxylase.

Heart valve disease: a journey of discovery

Master John of Arderne (1307-1380): a founder of modern surgery

Lessons for Cardiovascular Clinical Investigators: The Tumultuous 2,500-Year Journey of Physicians Who Ignited Our Fire

Pericardiectomy and Mechanical Mitro-Aortic Valve Replacement in a Young Patient With Erdheim-Chester Disease

Charles L Christian

Renaissance-Europe-17th Century

Fracture of the tibial tray following PCA knee replacement

Truncated ambition: Thomas King Chambers, MD (1817–1889)

50th Anniversary of the first successful permanent pacemaker implantation in the United States: historical review and future directions

Robert R. Shaw, MD: thoracic surgical hero, Afghanistan medical pioneer, champion for the patient, never a surgical society president

Oh, the places we’ll go

Historical landmarks in the development of robotic coronary bypass grafting